Safety assessment of Enterococcus lactis based on comparative genomics and phenotypic analysis

Jingda Lu, Tingting Shen, Yixin Zhang, Xinwei Ma, Sheng Xu, Sameh Awad, Muying Du, Zhi ZhongFrontiers in Microbiology 2023 · DOI

Abstract

Enterococcus faecium is sometimes used in food production; however, its acquisition of antibiotic resistance has become an alarming health concern. The E. lactis species is closely related to E. faecium and has good probiotic potential. This study aimed to investigate the antibiotic resistance of E. lactis. We analyzed the antibiotic resistance phenotype and whole-genome sequences of 60 E. lactis isolates (23, 29, and 8 isolates from dairy products, Rice wine Koji, and human feces, respectively). These isolates showed varying degree of resistance to 13 antibiotics, and were sensitive to ampicillin and linezolid. The E. lactis genomes carried only a subset of commonly reported antibiotic resistance genes (ARGs) in E. faecium. Five ARGs were detected across the investigated E. lactis, including two universally present genes (msrC and AAC(6')-Ii) and three rarely detected ARGs (tet(L), tetM, and efmA). To identify other undescribed antibiotic resistance-encoding genes, a genome-wide association study was performed, returning 160 potential resistance genes that were associated with six antibiotics, namely chloramphenicol, vancomycin, clindamycin, erythromycin, quinupristin-dalfopristin, and rifampicin. Only around one-third of these genes encode known biological functions, including cellular metabolism, membrane transport, and DNA synthesis. This work identified interesting targets for future study of antibiotic resistance in E. lactis. The fact that the lower number of ARGs present in E. lactis supports that it may be an alternative to E. faecalis for use in the food industry.

Introduction

Enterococci represent a complex group of lactic acid bacteria. While they are essential components in fermented food production and are frequently utilized as probiotics, species like Enterococcus faecalis and E. faecium are notorious opportunistic pathogens. Their capacity to acquire and spread multi-drug resistance, such as vancomycin resistance (VRE), is a significant clinical concern. Enterococcus lactis, a closely related species, shows great promise for probiotic applications. However, its safety—specifically its "resistome" (the collection of all antibiotic resistance genes)—requires thorough mapping to ensure it does not pose the same genomic risks as its pathogenic relatives.

Materials and Methods

The study analyzed 60 E. lactis isolates collected between 2007 and 2016, originating from natural fermented dairy products (23), Rice wine Koji (29), and human feces (8). The researchers employed a dual-track approach:

  1. Phenotypic Analysis: Antibiotic susceptibility testing was performed against 15 common antibiotics using the standard microbroth dilution method to determine Minimum Inhibitory Concentrations (MIC).
  2. Comparative Genomics: Whole-Genome Sequencing (WGS) was conducted on the Illumina HiSeq platform. Genomes were annotated using Prokka and Roary to define the core and pan-genomes.
  3. Safety Screening: Genomes were screened against the Comprehensive Antibiotic Resistance Database (CARD) and the Virulence Factor Database (VFDB).
  4. GWAS: A Genome-Wide Association Study (GWAS) using Scoary correlated phenotypic resistance data with gene presence/absence to identify novel potential resistance genes.
Pan-genome and core-genome accumulation curves for 60 E. lactis isolates.

Results and Discussion

Genomic Landscape and Niche Adaptation

The pan-genome analysis demonstrated a stable core genome alongside a diverse accessory genome. Interestingly, the study found evidence of niche adaptation; dairy-associated isolates generally possessed larger genomes and distinct metabolic toolkits compared to those from Koji or fecal sources. Variations in GC content across these groups further suggest that the environment significantly influences the genomic evolution of E. lactis.

GC content (%) distribution across different isolation sources (Dairy product, Rice wine Koji, and Human faeces).

Antibiotic Resistance and Safety Profile

Phenotypic testing revealed that while 95% of isolates were resistant to clindamycin and 93% to chloramphenicol, 100% remained sensitive to ampicillin and linezolid—critical "last-resort" antibiotics in human medicine.

Genomically, E. lactis appears significantly "cleaner" than E. faecium. Only five known ARGs were detected across the entire set, with only two (msrC and AAC(6')-Ii) being universal. The GWAS identified 160 potential resistance-encoding genes, many of which are associated with intrinsic cellular functions like membrane transport rather than the acquired resistance plasmids typically found in clinical strains. Furthermore, E. lactis lacked high-prevalence virulence factors common in other Enterococci, such as gelE (extracellular enzymes) and esp (surface proteins).

Conclusion

This comprehensive safety profile positions Enterococcus lactis as a safer candidate for use in the food and probiotic industries compared to its clinically problematic relatives. While the GWAS identified 160 candidate genes for antibiotic resistance, these results are correlative and require future functional validation. Expanding the dataset and investigating horizontal gene transfer (HGT) potential will be essential to ensure these isolates do not contribute to the spread of resistance within the food chain.

Summary updated

Abstract

<i>Enterococcus faecium</i> is sometimes used in food production; however, its acquisition of antibiotic resistance has become an alarming health concern. The <i>E. lactis</i> species is closely related to <i>E. faecium</i> and has good probiotic potential. This study aimed to investigate the antibiotic resistance of <i>E. lactis.</i> We analyzed the antibiotic resistance phenotype and whole-genome sequences of 60 <i>E. lactis</i> isolates (23, 29, and 8 isolates from dairy products, Rice wine Koji, and human feces, respectively). These isolates showed varying degree of resistance to 13 antibiotics, and were sensitive to ampicillin and linezolid. The <i>E. lactis</i> genomes carried only a subset of commonly reported antibiotic resistance genes (ARGs) in <i>E. faecium</i>. Five ARGs were detected across the investigated <i>E. lactis</i>, including two universally present genes (<i>msrC</i> and <i>AAC(6')-Ii</i>) and three rarely detected ARGs (<i>tet(L)</i>, <i>tetM</i>, and <i>efmA</i>). To identify other undescribed antibiotic resistance-encoding genes, a genome-wide association study was performed, returning 160 potential resistance genes that were associated with six antibiotics, namely chloramphenicol, vancomycin, clindamycin, erythromycin, quinupristin-dalfopristin, and rifampicin. Only around one-third of these genes encode known biological functions, including cellular metabolism, membrane transport, and DNA synthesis. This work identified interesting targets for future study of antibiotic resistance in <i>E. lactis</i>. The fact that the lower number of ARGs present in <i>E. lactis</i> supports that it may be an alternative to <i>E. faecalis</i> for use in the food industry. Data generated in this work is of interest to the dairy industry.
BibTeX
@inproceedings{lu2023safety,
  author = {Jingda Lu and Tingting Shen and Yixin Zhang and Xinwei Ma and Sheng Xu and Sameh Awad and Muying Du and Zhi Zhong},
  title = {{Safety assessment of Enterococcus lactis based on comparative genomics and phenotypic analysis}},
  booktitle = {Frontiers in Microbiology},
  year = {2023},
  doi = {10.3389/fmicb.2023.1196558},
}
Figure